Aurobindo Pharma Limited
AUROPHARMADrug Manufacturers - Specialty & Generic
₹1,659.90+0.92%As of Oct 29vs prior close
- Market cap
- $10B
- P/E (TTM)
- 26.2×
- P/E (FY1)
- 20.7×
- From 52W high
- −4.27%
- EPS (LTM)
- ₹63.33
- Revenue (LTM)
- ₹349.4B
- Net margin
- 10.63%
- Dividend yield
- 0.24%
Nomior Score
81
Ascendant MoverTop 2% of the scored universe
Growth67
Quality54
Value63
Momentum98
Resilience60
Growth
+10.69%revenue a year over 3 fiscal years
YE23 ₹246.2BLTM ₹349.4B
Connections
Revenue to profitYE26
10% of revenue became net profit, down 1 pt on a year.